Literature DB >> 15911235

beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.

Wanja Kildal1, Björn Risberg, Vera M Abeler, Gunnar B Kristensen, Jon Sudbø, Jahn M Nesland, Håvard E Danielsen.   

Abstract

The CTNNB1 gene and its product beta-catenin, a regulator of the Wnt signalling pathway, is often mutated and deregulated in human malignancies. Down stream targets of the Wnt signalling pathway are linked to genomic instability. In this study, the impact of beta-catenin expression on genomic instability in ovarian carcinoma, as determined by DNA ploidy, was investigated. Expression of beta-catenin was examined by immunohistochemistry in 253 ovarian carcinomas. The results were related to genomic instability and clinicopathological features of the patients. Membrane associated staining of beta-catenin was detected in nearly all cases with no correlation to clinical parameters. Most of the samples also had cytoplasmic (84%), while only 13% had nuclear beta-catenin localisation. A significant association between beta-catenin expression (cytoplasmic and nuclear) and histological subtype and degree of differentiation was observed. Nuclear beta-catenin was almost exclusively present in endometroid carcinomas. 53% of all endometroid tumours were positive for nuclear beta-catenin expression (P<0.0001). Mucinous carcinomas had the highest degree of cytoplasmic beta-catenin expression (92%), followed by endometroid (92%), mixed (90%), serous (82%), unclassified adenocarcinomas (81%), carcinomas clear cell and (70%), (P=0.01). Tumours with differentiation grade 1 (16%) and 2 (24%) had higher nuclear beta-catenin expression than grade 3 and clear cell carcinomas (6%) (P=0.012). Better prognostic outcome was found for patients with nuclear beta-catenin localisation as compared to the cases without (P=0.027). In conclusion, the study showed no correlation between beta-catenin expression in ovarian carcinoma and FIGO stage and genomic instability as determined by DNA ploidy status. However, nuclear beta-catenin expression was strongly associated with endometroid histological subtype. Finally, in ovarian cancer, although beta-catenin staining seems to be of prognostic importance with respect to nuclear staining in univariate analysis, only DNA ploidy status, histological grade and FIGO staging were of independent prognostic significance in multivariate analysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911235     DOI: 10.1016/j.ejca.2005.01.022

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  27 in total

Review 1.  Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.

Authors:  Jennifer R Ribeiro; Richard N Freiman
Journal:  J Steroid Biochem Mol Biol       Date:  2014-02-22       Impact factor: 4.292

Review 2.  Prognostic biomarkers in endometrial and ovarian carcinoma.

Authors:  Xavier Matias-Guiu; Ben Davidson
Journal:  Virchows Arch       Date:  2014-02-07       Impact factor: 4.064

3.  Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas.

Authors:  Hyeyeung Kim; Rong Wu; Kathleen R Cho; Dafydd G Thomas; Gabrielle Gossner; J Rebecca Liu; Thomas J Giordano; Kerby A Shedden; David E Misek; David M Lubman
Journal:  Proteomics Clin Appl       Date:  2008-03-07       Impact factor: 3.494

Review 4.  Wnt signaling in ovarian tumorigenesis.

Authors:  T A Gatcliffe; B J Monk; K Planutis; R F Holcombe
Journal:  Int J Gynecol Cancer       Date:  2007-11-06       Impact factor: 3.437

5.  Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats.

Authors:  Allison C Sharrow; Brigitte M Ronnett; Christopher J Thoburn; James P Barber; Robert L Giuntoli; Deborah K Armstrong; Richard J Jones; Allan D Hess
Journal:  J Ovarian Res       Date:  2010-03-31       Impact factor: 4.234

6.  Primary peritoneal serous carcinoma: a clinicopathological and immunohistochemical study of six cases.

Authors:  Teng Hou; Dongxia Liang; Jiehua He; Xu Chen; Yanna Zhang
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

7.  Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.

Authors:  Maria V Barbolina; Yiuying Liu; Hilal Gurler; Mijung Kim; Andre A Kajdacsy-Balla; Lisa Rooper; Jaclyn Shepard; Michael Weiss; Lonnie D Shea; Peter Penzes; Matthew J Ravosa; M Sharon Stack
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

8.  Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas.

Authors:  Chi-An Chen; Ying-Cheng Chiang; Ming-Cheng Chang; Yu-Hao Hu; San-Lin You; Yeu-Yao Kevin Cheng; Cheng-Yang Chou; Wen-Fang Cheng
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

9.  Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer.

Authors:  Liangdan Tang; Junzheng Yang; Shu-Kay Ng; Noah Rodriguez; Pui-Wah Choi; Allison Vitonis; Kui Wang; Geoffrey J McLachlan; Robert J Caiazzo; Brian C-S Liu; William R Welch; Daniel W Cramer; Ross S Berkowitz; Shu-Wing Ng
Journal:  Eur J Cancer       Date:  2010-01       Impact factor: 9.162

10.  Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer.

Authors:  Melissa A Merritt; Peter G Parsons; Tanya R Newton; Adam C Martyn; Penelope M Webb; Adèle C Green; David J Papadimos; Glen M Boyle
Journal:  BMC Cancer       Date:  2009-10-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.